×
Entrez Id:
55830
Gene Symbol:
GLT8D1
GLT8D1
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
2668
Gene Symbol:
GDNF
GDNF
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
6390
Gene Symbol:
SDHB
SDHB
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
0.100
Biomarker
phenotype
HPO
PPARGC1A
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
3145
Gene Symbol:
HMBS
HMBS
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
6863
Gene Symbol:
TAC1
TAC1
0.100
Biomarker
phenotype
BEFREE
Neurokinin 1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting : focus on fosaprepitant.
29130344
2018
×
Entrez Id:
1080
Gene Symbol:
CFTR
CFTR
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
3785
Gene Symbol:
KCNQ2
KCNQ2
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
22909
Gene Symbol:
FAN1
FAN1
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
1616
Gene Symbol:
DAXX
DAXX
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
9031
Gene Symbol:
BAZ1B
BAZ1B
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
6775
Gene Symbol:
STAT4
STAT4
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
5444
Gene Symbol:
PON1
PON1
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
10320
Gene Symbol:
IKZF1
IKZF1
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
8148
Gene Symbol:
TAF15
TAF15
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
6863
Gene Symbol:
TAC1
TAC1
0.100
Biomarker
phenotype
BEFREE
Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting : a Bayesian network meta-analysis.
31823054
2020
HLA-DPB1
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
6863
Gene Symbol:
TAC1
TAC1
0.100
Biomarker
phenotype
BEFREE
Rolapitant (Varubi) is a neurokinin-1 receptor antagonist approved for the prevention of chemotherapy-induced nausea and vomiting .
30422319
2019
×
Entrez Id:
1889
Gene Symbol:
ECE1
ECE1
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
4538
Gene Symbol:
ND4
ND4
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
6863
Gene Symbol:
TAC1
TAC1
0.100
Biomarker
phenotype
BEFREE
Rolapitant, a selective and long-acting neurokinin-1 receptor antagonist, is approved in an oral formulation for the prevention of delayed chemotherapy-induced nausea and vomiting in adults.
28906561
2017
×
Entrez Id:
23230
Gene Symbol:
VPS13A
VPS13A
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
2624
Gene Symbol:
GATA2
GATA2
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
4535
Gene Symbol:
ND1
ND1
0.100
Biomarker
phenotype
HPO